Virtus Investment Advisers, Inc. Silence Therapeutics PLC Transaction History
Virtus Investment Advisers, Inc.
- $289 Million
- Q1 2025
A detailed history of Virtus Investment Advisers, Inc. transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 24,872 shares of SLN stock, worth $137,293. This represents 0.02% of its overall portfolio holdings.
Number of Shares
24,872Holding current value
$137,293% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding SLN
# of Institutions
61Shares Held
22.7MCall Options Held
1.3KPut Options Held
2.6K-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$16.7 Million2.06% of portfolio
-
Siren, L.L.C. New York, NY2.79MShares$15.4 Million0.45% of portfolio
-
Redmile Group, LLC San Francisco, CA2.21MShares$12.2 Million0.66% of portfolio
-
Morgan Stanley New York, NY2MShares$11 Million0.0% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY1.85MShares$10.2 Million0.44% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $198M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...